MD Anderson Manual of Medical Oncology

MD Anderson Manual of Medical Oncology
PRP: 924,00 lei
Acesta este Prețul Recomandat de Producător. Prețul de vânzare al produsului este afișat mai jos.
Preț: 831,60 lei
Diferență: 92,40 lei
Disponibilitate: la comandă (vezi secțiunea "Despre livrare")
ISBN: 9781260467642
Anul publicării: 2022
Ediția: 4
Pagini: 1696
Categoria: Oncology


Expert, hands-on guidance for managing and treating all major cancers—from the world-renowned physicians at The MD Anderson Cancer Center

Comprehensive and authoritative, The MD Anderson Manual of Medical Oncology delivers everything readers need to accurately diagnose and effectively treat a wide range of cancers, including leukemia, lymphoma, myeloma, lung and breast cancer, genitourinary carcinoma, melanoma, and sarcoma. It emphasizes practical, actionable steps to cancer treatment, providing "to the point" recommendations, chapter summary boxes, tables, charts, expert opinion and patient education boxes, practice tips, cases, and prescriptive advice. The manual’s format quickly guides the reader to the topic, the affiliated relevant chapter, new findings affecting clinical practice, and reference/evidence.

  • Market: 17, 500 oncology professionals (medicine, nursing, physician assistants), 5, 000 hematologists (5000), 17, 000 trainees
  • NEW format helps readers get to the clinical bottom line quicker than ever
  • NEW Q&A, cases, patient education information, expert advice, and more
  • Expanded coverage of the rapidly developing area of immunotherapy treatment—written by the 2018 Nobel Prize-winner for immunology
  • Online: Customers get access continually updated content
  • Includes a comparative table with guidelines from the European Society of Medical Oncology and the American Society of Clinical Oncology


Part I: Leukemia
Section Editor:
Acute Lymphoblastic Leukemia

Adult Acute Myeloid Leukemia

Chronic Lymphocytic Leukemiaand Associated Disorders

Chronic Myeloid Leukemia

Myelodysplastic Syndromes: The MD Anderson Approach to Therapy

Part II: Lymphoma and Myeloma
Section Editor:
The Indolent Lymphomas

Aggressive and HighlyAggressive B Cell Lymphomas

T-cell Lymphomas

Hodgkin Lymphoma

Part III. Stem CellTransplantation
Section Editor:
Alternative Donor Transplants: Cord Blood Transplant

Alternative DonorTransplants-Haploidentical Hematopoietic Stem-Cell Transplantation

Part IV: Lung Cancer
Section Editor:
Small Cell Carcinoma of theLung

Non-small Cell Lung Cancer(sent in 3/6)
Part V: Head and Neck Cancer
Section Editor:
Head and Neck Cancer
Part VI: GastrointestinalCarcinomas
Section Editor: BobWolff
Gastric and Esophageal Cancer

Pancreatic Cancer

Hepatobiliary Malignancies

Small Bowel Cancer andAppendicle Tumors

Colorectal Cancer

Anal Cancer

Part VII: Breast Cancer
Section Editor:

Metastatic Breast Cancer

Special Situations in BreastCancer

Part VIII: GynecologicMalignancies
Section Editor:
Ovarian Cancer

Tumors of the Uterine Corpus

Tumorsof the Uterine Cervix
Gestational Trophoblastic Tumors

Part IX: GenitourinaryCarcinoma
Section Editor:
Renal Cell Carcinoma

Bladder Cancer

Prostate Cancer

Penile Cancer

Germ Cell Tumors

Part X. Neurologic Tumors
Section Editor:

Part XI. MalignantMelanoma and Sarcomas

Section Editor:

Malignant Melanoma
Soft Tissue and Bone Sarcomas

Part XII. Other Tumors

Section Editor:

43. Endocrine Malignancies

The AIDS-relatedCancers

Part XIII – Novel and OtherCancer Topics of Interest
Section Editors –

Carcinoma of Unknown Primary

Pediatric Cancers

Molecular Biomarkers andCancer

Immuno-Oncology (Jim Allison)
Targeted Therapies in Cancer
Applied Biostatistics

Part XIV. Supportive Care
Section Editor: DimitriosKontoyiannis
Fungal and Viral Infections inthe Cancer Patient
Endocrine and MetabolicComplications of Cancer Therapy
Oncologic Emergencies
Pulmonary Complications of CancerTherapy

Part XV Palliative Careand Symptom Management
Section Editor:
Palliative and SupportiveCare
Pain Management and SymptomControl
Long-term Survivorship inAdult and Pediatric Cancer


Hagop Kantarjian, MD, (Houston, TX) is Professor and Chair of the Department of Leukemia and the Samsung Distinguished Leukemia Chair in Cancer Medicine at The University of Texas MD Anderson Cancer Center. He is the author of 1, 800+ peer-reviewed publications, and his research and collaborations were the basis for FDA approvals of more than 20 leukemia.

Robert A. Wolff, MD, (Houston, TX) is Professor of Medicine in the Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center Deputy Division Head. He also serves as Clinical and Educational Affairs, Division of Cancer Medicine Program Director, Hematology/Oncology Fellowship.

Alyssa G. Rieber, MD, (Houston, TX) is Department Chair, Department of General Oncology, Division of Cancer Medicine Associate Professor; Department of General Oncology, Division of Cancer Medicine; Fellowship Program Associate Director, Division of Cancer Medicine; Center Medical Director, Division of MD Anderson Oncology Program at Lyndon B Johnson Hospital, The University of Texas MD Anderson Cancer Center.


Spune-ne opinia ta despre acest produs! scrie o recenzie
Created in 0.0428 sec